Qiming's Portfolio Company Abbisko Lists on Main Board of HK

/PRNewswire/ -- Qiming Venture Partners' portfolio company Abbisko (SEHK:2256), a clinical-stage biopharmaceutical company, listed on the main board of the...

Related Keywords

Shanghai , China , Hong Kong , Shenzhen , Guangdong , Suzhou , Jiangsu , Boston , Massachusetts , United States , Beijing , Qiming , Sichuan , Xiaomi , Fujian , Sanyou , Anhui , Venus Medtech , Cansino Biologics , Gan Lee Pharmaceuticals , Wedoctor Group , Zai Lab , Hong Kong Stock Exchange On , Shanghai Stock Exchange , Nasdaq , Astrazeneca , Shenzhen Stock Exchange , Horizon Health , Venture Partner , Hong Kong Stock Exchange , Venture Partners , Managing Partner , Qiming Venture Partners , San Francisco Bay , Gretai Securities Market , Lee Pharmaceuticals , Sanyou Medical , New Horizon Health , Berry Genomics ,